Keyword search (4,163 papers available)

"Rabi DM" Authored Publications:

Title Authors PubMed ID
1 Management of brain-heart multimorbidity: a clinical practice guideline Edwards JD; Li Z; McFarlane P; Rabi DM; Gilbert J; Bajaj HS; MacIntosh BJ; Bittman J; Feldman RD; Dresser G; Terenzi K; Swartz R; Gabor J; Pearson GJ; Selby P; Wharton S; Warburton DER; Pakhalé S; Styra R; Baker B; Tu K; Hawkins M; Stone JA; Vaillancourt T; Poon S; Virani SA; Jain R; Jones PH; Sandhu RK; Ganesh A; Andrade JG; Stern S; Habert J; Rivard L; Roumeliotis P; Udell JA; Campbell T; Bacon SL; Trudeau L; Keshavjee K; Pham T; Cheng G; Lewis KB; Maar M; Stacey D; Oldenburg B; Dhukai AR; Pasricha SV; Sh 41912243
HKAP
2 Ligne directrice C-CHANGE pour l’harmonisation des lignes directrices nationales de prévention et de prise en charge des maladies cardiovasculaires en contexte de soins primaires au Canada: mise à jour 2022 Jain R; Stone JA; Agarwal G; Andrade JG; Bacon SL; Bajaj HS; Baker B; Cheng G; Dannenbaum D; Gelfer M; Habert J; Hickey J; Keshavjee K; Kitty D; Lindsay P; L' Abbé MR; Lau DCW; Macle L; McDonald M; Nerenberg K; Pearson GJ; Pham T; Poppe AY; Rabi DM; Sherifali D; Selby P; Smith E; Stern S; Thanassoulis G; Terenzi K; Tu K; Udell J; Virani SA; Ward RA; Warburton DER; Wharton S; Zymantas J; Hua-Stewart D; Liu PP; Tobe SW; 36623864
HKAP
3 Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update Jain R; Stone JA; Agarwal G; Andrade JG; Bacon SL; Bajaj HS; Baker B; Cheng G; Dannenbaum D; Gelfer M; Habert J; Hickey J; Keshavjee K; Kitty D; Lindsay P; L' Abbé MR; Lau DCW; Macle L; McDonald M; Nerenberg K; Pearson GJ; Pham T; Poppe AY; Rabi DM; Sherifali D; Selby P; Smith E; Stern S; Thanassoulis G; Terenzi K; Tu K; Udell J; Virani SA; Ward RA; Warburton DER; Wharton S; Zymantas J; Hua-Stewart D; Liu PP; Tobe SW; 36343954
HKAP
4 Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, Butalia S, Leung AA, Harris KC, Cloutier L, Zarnke KB, Ruzicka M, Hiremath S, Feldman RD, Tobe SW, Campbell TS, Bacon SL, Nerenberg KA, Dresser GK, Fournier A, Burgess E, Lindsay P, Rabkin SW, Prebtani APH, Grover S, Honos G, Alfonsi JE, Arcand J, Audibert F, Benoit G, Bittman J, Bolli P, Côté AM, Dionne J, Don-Wauchope A, Edwards C, Firoz T, Gabor JY, Gilbert RE, Grégoire JC, Gryn SE, Gupta M, Hannah-Shmouni F, Hegele RA, Herman RJ, H 32389335
HKAP
5 Prolonged hypothalamic-pituitary-adrenal axis activation after acute coronary syndrome in the GENESIS-PRAXY cohort. Tang AR, Rabi DM, Lavoie KL, Bacon SL, Pilote L, Kline GA 28969495
HKAP
6 Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update. Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, Ezekowitz JA, Gregoire JC, Gubitz G, Jain R, Keshavjee K, Lindsay P, L'Abbe M, Lau DCW, Leiter LA, O'Meara E, Pearson GJ, Rabi DM, Sherifali D, Selby P, Tu JV, Wharton S, Walker KM, Hua-Stewart D, Liu PP 30301743
HKAP

 

Title:Prolonged hypothalamic-pituitary-adrenal axis activation after acute coronary syndrome in the GENESIS-PRAXY cohort.
Authors:Tang ARRabi DMLavoie KLBacon SLPilote LKline GA
Link:https://www.ncbi.nlm.nih.gov/pubmed/28969495?dopt=Abstract
Publication:
Keywords:
PMID:28969495 Category:Eur J Prev Cardiol Date Added:2019-05-31
Dept Affiliation: HKAP
1 1 Department of Medicine, University of Calgary, Canada.
2 2 Department of Community Health Sciences, University of Calgary, Canada.
3 3 Montreal Behavioural Medicine Centre, Hopital du Sacre-Coeur de Montreal, Canada.
4 4 Department of Psychology, Université du Québec, Canada.
5 5 Department of Exercise Science, Concordia University, Canada.
6 6 Department of Medicine, McGill University, Canada.

Description:

Prolonged hypothalamic-pituitary-adrenal axis activation after acute coronary syndrome in the GENESIS-PRAXY cohort.

Eur J Prev Cardiol. 2018 01;25(1):65-72

Authors: Tang AR, Rabi DM, Lavoie KL, Bacon SL, Pilote L, Kline GA

Abstract

Background Glucocorticoid excess has been linked with cardiovascular disease. Little is known about the long-term cortisol response in patients after acute coronary syndrome. Design The objective of this study was to describe the distribution of salivary cortisol in the post-acute phase of acute coronary syndrome and to describe the association of late-night salivary cortisol with cardiovascular risk factors. Methods We used late-night salivary cortisol measurements post-discharge to estimate hypothalamic-pituitary-adrenal axis activity in 309 patients aged 18-55 years enrolled in the GENESIS-PRAXY study from January 2009-April 2013. We evaluated hypothalamic-pituitary-adrenal axis activity and its association with hypertension, dyslipidemia, diabetes, smoking, family history, prior acute coronary syndrome, psychiatric diseases, acute coronary syndrome severity, as well as mortality and rate of rehospitalization at 12 months. Results Persistently elevated late-night salivary cortisol>2.92?nmol/l was seen in 99 (32.0%) patients: within the range of what may be seen in Cushing's disease. Elevated late-night salivary cortisol was associated with previous acute coronary syndrome (13.3% vs 24.2%, p?=?0.02), peripheral vascular disease (3.8% vs 13.1%, p?=?0.002), and smoking (32.9% vs 46.5% p?=?0.02). Elevated late-night salivary cortisol was associated with higher hemoglobin A1c values (5.6?±?3.0 vs 6.1?±?2.9, p?=?0.008) and lower high density lipoprotein values (0.94?±?0.53 vs 0.86?±?0.50, p?=?0.01). There were no differences in psychiatric symptom scores, acute coronary syndrome severity or mortality, and rate of rehospitalization at 12 months. Conclusions Many patients post-acute coronary syndrome have prolonged, marked activation of the hypothalamic-pituitary-adrenal axis. Late-night salivary cortisol co-associates with several cardiovascular risk factors. Further studies are needed to confirm the exact role of hypothalamic-pituitary-adrenal axis activity in the pathophysiology of cardiovascular disease.

PMID: 28969495 [PubMed - indexed for MEDLINE]





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University